
E-CFCP is a novel long-acting nucleotide reverse transcriptase ингибитор (NRTI) against HBV, shows мощный activity against HBV WTD1 and HBV WTC2 с IC50 of 1.8 and 0.7 nM, respectively.
E-CFCP is a novel long-acting nucleotide reverse transcriptase inhibitor (NRTI) against HBV, shows potent activity against HBV WTD1 and HBV WTC2 with IC50 of 1.8 and 0.7 nM, respectively.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.